Omics! Omics!

Given it's late and I just dashed through a classic San Francisco downpour, I'm going to mostly stick to covering Clive Brown's ...

Nanopore Community Meeting begins within the hour.  San Francisco is spectacular as ever -- Alcatraz Island disappearing into the fog as I f...

Okay, now that I'm done venting -- for now -- about ONT's customer service experience   (well, almost done -- they sent me the same ...

I'd planned today to use some downtime to write up a preview of the Nanopore Community Meeting which I am attending tomorrow and Thursda...

I took one swing at Vijay Pande's overly rosy piece on applying engineering methods to biology and medicine  and similar minded efforts...

Vijay Pande has a thought-provoking piece in Scientific American on the Groves Fallacy , though in the end I'm afraid mostly what he pro...

Illumina surprised pretty much everyone in the genomics community by announcing the purchase of Pacific Biosciences.  I had spent Thursday d...

Yes, it's been way too long since I wrote here.  Even longer since I did so with any regularity.  There was always some list of things d...

I've been horribly neglecting this space for an extended period.  Contributors to that include a TNG eclosing from high school, ferrying...

In my preview ahead of London Calling , I suggested that VolTRAX is a device that still hasn't found its raison d'etre.  With the me...

London Calling has been over for nearly three weeks.  I originally wanted to write up at least something after the first night, but fatigue ...

It's the night before London Calling. I hope to post Thursday, but an after-meeting report won’t be until nest week - I must dash on F...

Editorial note: I wrote this in early January, then planned to slot it in after some other items.  Then life knocked me upside the head , th...

I was at a get-together yesterday for bioinformatics folks associated with Third Rock Ventures companies at a local pub.  The organizer, who...

Back in October I covered the launch of Mission Bio 's single cell platform, Tapestri.  Tapestri is a microfluidic platform which encap...

A movie opened this weekend which, by all prior evidence and new reviews, is unbelievably silly but destined to rake in the bucks. Rampage ...

If you are in the sequencing business, you'd like to get things right.  But sequencing is a form of measurement and measurement has erro...

I've written in the past about SeqLL , the company which purchased all of the hard assets from Helicos after the latter's demise.  A...

Due to the usual time conflicts, I've only watched bits-and-pieces of the Winter Olympics from South Korea. Which is unfortunate, as I d...

AGBT officially ended on Thursday night with a space-themed party, but I have a bunch of notes from interviews with company representatives ...